During the past nine years, the DERC, with its Core Laboratories, Enrichment Program and support for Pilot and Feasibility. studies, has played a major role in allowing for expansion in the scope and intensity of research at the Joslin Diabetes Center and Harvard Medical School. The DERC has provided essential support for interdisciplinary studies and junior faculty, and a critical infrastructure for both basic and clinical research. It is not surprising, therefore, that over his period there has been a further strengthening of the research effort at the Joslin, a significant increase in the publications in peer-reviewed journals and a more than 50% increase in training of research fellows. Recognizing this growth in research activity and the importance of the research mission, the Joslin added three floors to its building with over 30,000 sq. ft. of additional research space, and has renovated research space in the original building, all of which has resulted in improved laboratory space for individual investigators and the DERC Core Laboratories. In this renewal application, we have attempted to build on those strengths by eliminating Core Laboratories which were underutilized (such as Flow Cytometry) and adding new Cores (such as the Computer Resource Core). In addition, we have expanded the scope of the services provided by most Cores, but especially, the Peptide Biochemistry Core, the Microscopy Core, the Radioligand Assay Laboratory for the Clinical Research Core and the Transgenic Animal Core. At the last renewal we added one Pilot and Feasibility grant to our Center for use by scientists in the Longwood area outside the Joslin and affiliated with Harvard hospitals (e.g. Harvard Medical School, Children's Hospital, Beth Israel Hospital, Brigham and Women's Hospital, Deaconess Hospital, Dana Farber Cancer Institute, Center for Blood Research and Massachusetts General Hospital), and this program will continue. Within the DERC and the Joslin we have been particularly encouraged over the past four years by the development of younger faculty who have bean supported directly and indirectly by the DERC, such as Drs. Jackson, White, Hattori, Maratos-Flier, Rhodes, Shoelson, Lipes, Goodyear and others. These individuals, along with more established investigators and new faculty recruited by virtue of expansion, create the scientific base and strength of the Joslin DERC. Finally, the strong intellectual stimulus provided by the activities of the Enrichment Program have a major impact, not only at the Joslin, but in the whole Harvard-Longwood Medical area.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK036836-11
Application #
2016186
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (08))
Program Officer
Fradkin, Judith E
Project Start
1986-09-30
Project End
2001-11-30
Budget Start
1997-02-15
Budget End
1997-11-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Rezanejad, Habib; Ouziel-Yahalom, Limor; Keyzer, Charlotte A et al. (2018) Heterogeneity of SOX9 and HNF1? in Pancreatic Ducts Is Dynamic. Stem Cell Reports 10:725-738
Katz, Michelle L; Guo, Zijing; Cheema, Alina et al. (2018) Management of Cardiovascular Disease Risk in Teens with Type 1 Diabetes: Perspectives of Teens With and Without Dyslipidemia and Parents. Pediatr Diabetes :
Gordin, Daniel; Harjutsalo, Valma; Tinsley, Liane et al. (2018) Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 41:815-822
Teló, G H; Dougher, C E; Volkening, L K et al. (2018) Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes. Diabet Med 35:1355-1363
Srinivasan, Shylaja; Kaur, Varinderpal; Chamarthi, Bindu et al. (2018) TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). Diabetes Care 41:554-561
Goldford, Joshua E; Lu, Nanxi; Baji?, Djordje et al. (2018) Emergent simplicity in microbial community assembly. Science 361:469-474
Soto, Marion; Orliaguet, Lucie; Reyzer, Michelle L et al. (2018) Pyruvate induces torpor in obese mice. Proc Natl Acad Sci U S A 115:810-815
Karst, Sonja G; Lammer, Jan; Radwan, Salma H et al. (2018) Characterization of In Vivo Retinal Lesions of Diabetic Retinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy. Int J Endocrinol 2018:7492946
Espeland, Mark A; Carmichael, Owen; Hayden, Kathleen et al. (2018) Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci 73:484-491
Kim, Youngjo; Bayona, Princess Wendy; Kim, Miri et al. (2018) Macrophage Lamin A/C Regulates Inflammation and the Development of Obesity-Induced Insulin Resistance. Front Immunol 9:696

Showing the most recent 10 out of 1120 publications